Gibson Dunn & Crutcher is advising Immedica Pharma AB on the transaction and Hogan Lovells is advising Marinus Pharmaceuticals, Inc. Immedica Pharma AB (Immedica), a leading...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here